All samples·Sample analysis
Get your own pass — $199
granted.bioAll samples
Analysis

radioligand therapy for prostate cancer

Overview
  • Dashboard
Analysis
  • What Surprised Us
  • Field Maturity
  • Funding Landscape
  • Competitive Topology
  • White Space
  • Market Context
Data
  • Projects115
  • Clinical Trials500
  • Patents29
  • Publications646
  • Organizations52
  • Researchers125
Reference
  • Methodology
Back
radioligand therapy for prostate cancerOrganizationsICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

Projects attributed to ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI within this analysis sample.

In This Analysis
Projects
2
NIH Funding
$1.8M
Projects(2)
ProjectPICategoryFunding
Functional Characterization and Development of Therapeutic Paradigms for DNA Damage Repair (DDR)-deficient Lethal Prostate Cancer
5R01CA274967-03
CHAKRABORTY, GOUTAMTherapeutics$1.4M
Targeting the Androgen Receptor to Sensitize Bladder Cancer to Immune Check Point Blockade.
R21CA286309
MULHOLLAND, DAVID (contact)Basic Research$435K
See ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI’s full platform profile
Cross-source view across the entire granted.bio dataset — projects, trials, patents, and publications spanning every topic, not just this analysis.